StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.82−0.11 (-11.31%)

Close on Nov 18, 2026Market cap $3.65MP/E –Yield –

Kiora Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Kiora Pharmaceuticals's price to sales ratio was 390.1× on Jul 31, 2025, against 0.8× a year earlier. Over the last 5 years it ranged from 0.6× to 478.8×, with a median of 101.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 2025390.1×+389.5
2024Dec 31, 20240.6×−7.1
2020Apr 30, 20207.7×−3.3
2019Dec 31, 201911.1×−167.9
2018Dec 31, 2018178.9×−295.4
2017Dec 29, 2017474.4×+25.1
2016Dec 30, 2016449.3×–

More Kiora Pharmaceuticals figures

See a number that looks wrong?